BIO

Bioage Labs Announces Multi-Year Collaboration With Novartis to Discover Novel Targets for Therapies That Address Age-Related Diseases and Conditions

时间:2024-12-18 22:00:03 市场: 美股 综合

关联: BIOA

Zenas Biopharma Inc : Morgan Stanley Cuts Target Price to $35.00 From $40.00

时间:2024-12-11 18:51:13 市场: 美股 综合

关联: ZBIO

Biora Therapeutics Inc - Nasdaq to Delist Biora Therapeutics Due to Non-Compliance

时间:2024-12-10 20:01:43 市场: 综合 美股

关联: BIOR

Bioage Labs Falls 76.9% After Jefferies Cuts PT on Co

时间:2024-12-09 22:37:23 市场: 综合 美股

关联: BIOA

Bioage Labs Announces Discontinuation of Strides Phase 2 Clinical Trial Evaluating Azelaprag in Combination With Tirzepatide for the Treatment of Obesity

时间:2024-12-07 05:35:19 市场: 美股 综合

关联: BIOA

Bioage Labs Inc - Decision Follows Observations of Liver Transaminitis Without Clinically Significant Symptoms in Some Subjects on Azelaprag

时间:2024-12-07 05:35:19 市场: 美股 综合

关联: BIOA

Bioage Labs Inc - No Transaminase Elevations in Tirzepatide Only Group

时间:2024-12-07 05:35:19 市场: 美股 综合

关联: BIOA

Bioage Labs Inc - Dosing Discontinued, No Additional Subjects to Be Enrolled

时间:2024-12-07 05:35:19 市场: 美股 综合

关联: BIOA

Harvard Bioscience Inc Files for Mixed Shelf of up to $100 Mln - SEC Filing

时间:2024-12-06 20:46:29 市场: 美股 综合

关联: HBIO

Biome Technologies - Trading Update and Board Change

时间:2024-12-04 15:00:04 市场: 综合

关联: BIOM.UK